Not logged inCTX130 allogeneic CRISPR-Cas9-engineered chimeric antigen receptor (CAR) T cells in patients with advanced clear cell renal cell carcinoma: Long-term follow-up and translational data from the phase 1 COBALT-RCC study
Pal, Sumanta Kumar; Tran, Ben; Haanen, John B.; Hurwitz, Michael; Sacher, Adrian; Agarwal, Neeraj; Tannir, Nizar; Budde, Elizabeth; Harrison, Simon; Klobuch, Sebastian; Patel, Sagar S.; Dequeant, Mary-Lee; He, Qiuling Ally; Keegan, Alissa; Dar, Henia; Ma, Anna; Morrow, P. K.; Srour, Samer A. .png)
Share.png)
SaveShare Save CTX130 ALLOGENEIC CRISPR-CAS9-ENGINEERED CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS IN PATIENTS WITH ADVANCED CLEAR CELL RENAL CELL CARCINOMA: RESULTS FROM THE PHASE 1 COBALTRCC STUDYPal, Sumanta; Tran, Ben; Haanen, John; Hurwitz, Michael; Sacher, Adrian; Agarwal, Neeraj; Tannir, Nizar; Budde, Elizabeth; Harrison, Simon; Klobuch, Sebastian; Patel, Sagar; Dequeant, Mary Lee; Karsten, Verena; Cohen, Kaitlyn; Gurary, Ellen; Dar, Henia; Ma, Anna; Sharma, Anjali; Srour, Samer Share Save Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
